Honda ROV Recall Issued After Reports Of Vehicles Moving While Parked

Honda has announced a recall that impacts 25,000 off-road vehicles which have the potential to move when in the park position, posing a roll away and injury hazard for occupants exiting the vehicle, as well as bystanders.

The U.S. Consumer Product Safety Commission (CPSC) announced the Honda recreational off-highway vehicle (ROV) recall on June 18, following at least three consumer reports of the vehicles moving while the shifter was placed in the park position. To date, no injuries or accidents have reported in relation to the recall, but serious and sometimes fatal injuries have been linked to similar problems with other vehicles.

The recall involves certain model year 2019 and 2020 Pioneer 1000 and Talon 1000 side-by-side off road vehicles sold in various colors including red, blue, green, gray and yellow and have the manufacturer name “Honda” printed on the front, sides and rear of the vehicle.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The vehicles were manufactured in the United States by American Honda Motor Co. Inc., of Torrance, California. They were distributed for sale throughout the United States to authorized Honda power sports dealers from November 2018 through March 2020 for between $15,000 and $24,000.

To date, Honda has received three consumer complaints indicating the ROV’s moved while the brake was engaged and in the park position.

Rollaway incidents can be extremely dangerous and even fatal for occupants and those nearby, especially when the vehicle is parked on an incline.

Customers are being instructed to stop using the ROV’s immediately and to keep the vehicles parked on level surfaces where they cannot roll away.

Honda announced it will begin notifying customers of the issue and will provide instructions on how to schedule a repair appointment at their local authorized dealer, where dealers will be instructed to inspect and repair the brake, free of charge.

For additional questions or concerns regarding the recall, customers may contact American Honda toll-free at 866-784-1870 and reference the recall number 20-751.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.